Abstract P2-14-11: Immune response monitoring in breast cancer patients treated with neoadjuvant chemotherapy combined with dendritic cell vaccines
Laura Hato(Unknown), Ascensión López(Clinica Universidad de Navarra), Belén Pérez(Centro de Investigación Biomédica en Red), Marta Santisteban(Navarre Institute of Health Research), Luis D. Mejías(Clinica Universidad de Navarra), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Susana Inogés(Universidad de Navarra)
Cited by 1
Related Papers
Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells
|Cancer Research|2009|378
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry
|British Journal of Cancer|2017|106
Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early Breast Cancer
|JAMA Oncology|2024|77
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer
|Nature Communications|2023|65
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
|European Journal of Surgical Oncology|2018|60